PRIMARY STUDY

Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death.

Key Findings:  Treatment of mice with cannabidiol markedly attenuated the cisplatin-induced oxidative/nitrosative stress, inflammation, and cell death in the kidney, and it improved renal function. Thus, the results suggest that cannabidiol may represent a promising new protective strategy against cisplatin-induced nephrotoxicity.

Type of Study:  Animal Study

Study Result:  Positive

Study Location(s):  China, United States

Year of Pub:  2009


Cannabinoids Studied:  Cannabidiol (CBD)

Chemotype:  Chemotype III

Ligands Studied:  Anti-inflammatory cytokines, Pro-inflammatory cytokines

Sub-Ratio: 0:1 (THC:CB

Dosage: CBD (2.5 to 10 mg/kg i.p. daily, starting 1.5 h before the cisplatin exposure)

Route of Administration:  Injection



Link to study